Kolexia
Brousse Valentine
Pédiatrie
Hôpital Robert-Debré
Paris, France
168 Activités
468 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose Anémie Thalassémie Bêta-Thalassémie Accident vasculaire cérébral Surcharge en fer Hémoglobinopathies Syndrome thoracique aigu Réaction transfusionnelle

Industries

Vertex
10 collaboration(s)
Dernière en 2023
Celgene
4 collaboration(s)
Dernière en 2021
Novartis
3 collaboration(s)
Dernière en 2023
FORMA THERAPEUTICS, INC.
3 collaboration(s)
Dernière en 2022

Dernières activités

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.
Haematologica   22 février 2024
Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.
American journal of hematology   22 janvier 2024
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   08 janvier 2024
Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   13 octobre 2023
Severity and burden of sickle cell disease (SCD) in France: A nationwide real-world study
Abstracts of ICPE 2023, the 39th international conference on pharmacoepidemiology and therapeutic risk management (ICPE), 25–27 August 2023, Halifax, Canada   12 octobre 2023
Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014-2019.
Pediatrics   09 octobre 2023
Global burden of sickle cell disease in 2021.
The Lancet. Haematology   06 octobre 2023
Severity and burden of sickle cell disease in France: a nationwide real-world study.
Haematologica   01 septembre 2023
Transfusion requirements and complication rate in β-thalassemia intermedia due to heterozygous β-globin gene mutation and triplicated α-globin genes.
European journal of haematology   30 juillet 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023